/abl-bio-expands-strategic-collaboration-with-wuxi-biologics-and-licenses-wuxibody-platform-for-novel-immune-check-point-bispecifics-for-220-million/ 提供端到端一站式解决方案 Fri, 16 Jul 2021 07:50:24 +0000 hourly 1